Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection

Rosenthal P, Schwarz KB, Gonzalez-Peralta RP, et al. Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2019;doi: 10.1002/hep.30821. [Epub ahead of print].

Publication Type:

Journal Article

Authors:

Rosenthal, P; Schwarz, KB; Gonzalez-Peralta, RP; et, al

Source:

Hepatology, Volume doi: 10.1002/hep.30821. [Epub ahead of print] (2019)

Cited On:

Export Citation:
RIS Format
Top